Yoshitaka Itami

633 total citations
38 papers, 409 citations indexed

About

Yoshitaka Itami is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoshitaka Itami has authored 38 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 14 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoshitaka Itami's work include Bladder and Urothelial Cancer Treatments (14 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Urinary and Genital Oncology Studies (6 papers). Yoshitaka Itami is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Urinary and Genital Oncology Studies (6 papers). Yoshitaka Itami collaborates with scholars based in Japan and United States. Yoshitaka Itami's co-authors include Kiyohide Fujimoto, Makito Miyake, Shunta Hori, Nobumichi Tanaka, Yasushi Nakai, Satoshi Anai, Yosuke Morizawa, Takuya Owari, Daisuke Gotoh and Kazumasa Torimoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Cells.

In The Last Decade

Yoshitaka Itami

32 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshitaka Itami Japan 11 188 174 100 82 80 38 409
Kota Iida Japan 11 228 1.2× 165 0.9× 113 1.1× 69 0.8× 116 1.4× 38 441
T Igarashi Japan 10 123 0.7× 148 0.9× 80 0.8× 53 0.6× 98 1.2× 26 436
Luana Franceschilli Italy 17 553 2.9× 268 1.5× 56 0.6× 130 1.6× 49 0.6× 38 839
Jake Patterson United Kingdom 8 235 1.3× 49 0.3× 81 0.8× 47 0.6× 106 1.3× 20 387
Rose K. C. Moritz Germany 12 166 0.9× 98 0.6× 65 0.7× 91 1.1× 102 1.3× 33 470
Yuan‐Tso Cheng Taiwan 13 304 1.6× 172 1.0× 154 1.5× 24 0.3× 94 1.2× 60 582
Madhuri Gawande India 13 89 0.5× 72 0.4× 59 0.6× 13 0.2× 88 1.1× 64 479
William A. Stinson Canada 13 130 0.7× 74 0.4× 144 1.4× 177 2.2× 202 2.5× 27 538
Long Huang China 12 89 0.5× 103 0.6× 52 0.5× 35 0.4× 111 1.4× 43 369
G. Klöppel Germany 10 236 1.3× 83 0.5× 75 0.8× 17 0.2× 66 0.8× 34 392

Countries citing papers authored by Yoshitaka Itami

Since Specialization
Citations

This map shows the geographic impact of Yoshitaka Itami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Itami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Itami more than expected).

Fields of papers citing papers by Yoshitaka Itami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Itami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Itami. The network helps show where Yoshitaka Itami may publish in the future.

Co-authorship network of co-authors of Yoshitaka Itami

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Itami. A scholar is included among the top collaborators of Yoshitaka Itami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Itami. Yoshitaka Itami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Itami, Yoshitaka, et al.. (2024). CLINICAL EVALUATION OF THERAPEUTIC EFFECT PREDICTORS IN PEMBROLIZUMAB FOR ADVANCED UROTHELIAL CANCER. The Japanese Journal of Urology. 115(1). 1–10.
2.
4.
Tachibana, Akira, et al.. (2023). Composite pheochromocytoma associated with neurofibromatosis type 1. SHILAP Revista de lepidopterología. 6(5). 278–281. 1 indexed citations
5.
Gotoh, Daisuke, Kazumasa Torimoto, Takashi Iwamoto, et al.. (2022). Efficacy of medical expulsive therapy using the traditional Japanese medicine (kampo) choreito for the spontaneous passage of proximal ureteric stones: A retrospective analysis. Traditional & Kampo Medicine. 9(2). 83–88. 1 indexed citations
6.
Itami, Yoshitaka, et al.. (2022). IMPACT OF THE SPREAD OF COVID-19 ON THE UROLOGY PRACTICE IN OUR HOSPITAL. The Japanese Journal of Urology. 113(3). 83–89.
8.
Miyake, Makito, Yoshihiro Tatsumi, Shunta Hori, et al.. (2020). Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model. Asian Pacific Journal of Cancer Prevention. 21(12). 3743–3749. 4 indexed citations
10.
Gotoh, Daisuke, Katsuya Aoki, Yosuke Morizawa, et al.. (2020). A Japanese man with spina bifida who successfully fathered a child following fertility treatment. SHILAP Revista de lepidopterología. 3(3). 90–92. 1 indexed citations
11.
Itami, Yoshitaka, Makito Miyake, Sayuri Ohnishi, et al.. (2020). Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder. Diagnostics. 10(1). 54–54. 9 indexed citations
12.
Hori, Shunta, Yosuke Morizawa, Daisuke Gotoh, et al.. (2019). Evaluation of Preoperative Abdominal Adipose Tissue–, Inflammation-, Muscle Mass–, and Nutritional Status–based Prognostic Markers to Assess Renal Dysfunction in Living Kidney Donors. Transplantation Proceedings. 51(6). 1706–1716. 4 indexed citations
13.
Miyake, Makito, Daisuke Gotoh, Yoshiaki Matsumura, et al.. (2019). The diagnostic utility of retroperitoneoscopic tissue biopsy for unresectable retroperitoneal lesions excluding urogenital cancers. World Journal of Surgical Oncology. 17(1). 35–35. 3 indexed citations
14.
Itami, Yoshitaka, Makito Miyake, Yoshihiro Tatsumi, et al.. (2019). Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy. International Journal of Clinical Oncology. 24(5). 533–545. 33 indexed citations
15.
Miyake, Makito, Shunta Hori, Sayuri Ohnishi, et al.. (2019). Supplementary granulocyte macrophage colony‐stimulating factor to chemotherapy and programmed death‐ligand 1 blockade decreases local recurrence after surgery in bladder cancer. Cancer Science. 110(10). 3315–3327. 18 indexed citations
16.
Miyake, Makito, Kenta Ohnishi, Shunta Hori, et al.. (2019). Mycoplasma genitalium Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy Specimens. Cells. 8(3). 212–212. 60 indexed citations
17.
Hori, Shunta, Makito Miyake, Yoshihiro Tatsumi, et al.. (2019). Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment. Oncology Reports. 41(3). 1863–1874. 7 indexed citations
18.
Itami, Yoshitaka, et al.. (2015). [The efficacy of the use of acetic acid test in a case of local recurrence of penile carcinoma].. PubMed. 61(3). 103–7.
19.
Itami, Yoshitaka, et al.. (2012). [Clinical utility of measurement of procalcitonin for diagnosis of urosepsis].. PubMed. 58(10). 539–42. 1 indexed citations
20.
Itami, Yoshitaka, Nobutaka Shimizu, Yasuyuki Kobayashi, et al.. (2012). [A case of primary urotherial carcinoma with glandular differentiation of the renal pelvis with high serum level of carbohydrate antigen 19-9 (CA19-9)].. PubMed. 58(4). 203–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026